Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection

Cyclosporine formulations for use in the prevention or treatment of pulmonary chronic graft rejection

US Patent 10857198 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aerosol delivery device and operating method for the aerosol delivery device2025
Inhalable compositions comprising macrocyclic immunosuppressants2025
Inhalable compositions for use in the treatment of pulmonary diseases2025
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2024
Inhalable compositions for use in the treatment of pulmonary diseases2024
Cyclosporine formulations for use in the prevention or treatment of pulmonary ch2023
Cyclosporine formulations for use in the prevention or treatment of pulmonary ch2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2023
Aerosol delivery device and operating method for the aerosol delivery device2023
Cyclosporine formulations for use in the treatment of bronchiolitis obliterans s2022
Inhalable compositions for use in the treatment of pulmonary diseases2022
Chip card2009